Stock Quote

FDA advisory committee to vote on Johnson & Johnson COVID-19 booster, a day after endorsing the Moderna one

One day after a U.S. Food and Drug Administration advisory panel voted to endorse a booster shot of the Moderna vaccine for seniors and other at-risk groups, it will reconvene to discuss a booster shot of Johnson & Johnson's one-dose regimen and weigh in on who, if anyone, should be offered one of those.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.